Showing results (11-20 of 115) with videos related to
Sort By:
Pageof 12
Parasite Immunology|August 21, 2009
The development of the RTS,S malaria vaccine candidate: challenges and lessonsW R BallouJournal of Immunological Methods|November 11, 1983
Dot enzyme-linked immunosorbent assay (Dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasisM G Pappas, R Hajkowski, W T HockmeyerScience (New York, N.Y.)|April 15, 1988
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malariaJ C Sadoff, W R Ballou, L S Baron, et al.Science (New York, N.Y.)|May 24, 1985
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccineJ F Young, W T Hockmeyer, M Gross, et al.Lancet (London, England)|June 6, 1987
Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccineW R Ballou, S L Hoffman, J A Sherwood, et al.Vaccine|December 1, 1989
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid AR L Richards, G M Swartz, C Schultz, et al.Veterinary Parasitology|June 1, 1984
Dot enzyme-linked immunosorbent assay (Dot-ELISA): comparison with standard ELISA and complement fixation assays for the diagnosis of human visceral leishmaniasisM G Pappas, R Hajkowski, L T Cannon, et al.Clinical Immunology and Immunopathology|March 1, 1985
Reduced false positive reactions in the Dot-enzyme-linked immunosorbent assay for human visceral leishmaniasisM G Pappas, R Hajkowski, D B Tang, et al.Infection and Immunity|July 1, 1978
Further characterization of Mycobacterium ulcerans toxinW T Hockmeyer, R E Krieg, M Reich, et al.Current Opinion in Infectious Diseases|October 13, 2006
Malaria in 1998: advances in diagnosis, drugs and vaccine developmentD G Heppner, W R BallouPageof 12